OUTFOX BIO LIMITED

13786991
Active Didcot

Research and experimental development on biotechnology

7 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
O

OUTFOX BIO LIMITED

13786991

Research and experimental development on biotechnology

Founded 7 Dec 2021 Active Didcot, England 7 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

NANOVATION THERAPEUTICS UK LTD 7 Dec 2021 — 20 Nov 2024
Accounts Submitted 2 Jun 2026 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 22 Dec 2025 Next due 20 Dec 2026 6 months remaining
Net assets £472K £108K 2024 year on year
Total assets £517K £96K 2024 year on year
Total Liabilities £45K £12K 2024 year on year
Charges 2
1 outstanding 1 satisfied

Contact & Details

Contact

Registered Address

Rutherford Appleton Laboratory Harwell Oxford Didcot OX11 0FA England

Website

www.example.com

Full company profile for OUTFOX BIO LIMITED (13786991), an active life sciences and medical technology company based in Didcot, England. Incorporated 7 Dec 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type total-exemption-full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2022–2024)

Cash in Bank

£189.25k

Net Assets

£472.07k

Increased by £107.60k (+30%)

Total Liabilities

£45.32k

Decreased by £11.81k (-21%)

Turnover

N/A

Employees

7

Debt Ratio

9%

Decreased by 5 (-36%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

3 Allotments 7,500,000 Shares £750k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
2 Dec 20252,500,000£250k£0.1
17 Jul 20252,500,000£250k£0.1
18 Sept 20242,500,000£250k£0.1

Officers

Officers

3 active
Status
Jonathan David MooreDirectorBritishUnited Kingdom593 Jul 2025Active
Molly StevensDirectorBritishUnited Kingdom527 Dec 2021Active
Pieter Rutter CullisDirectorCanadianCanada807 Dec 2021Active

Shareholders

Shareholders (1)

Hextwo Capital Inc
100.0%
20,990,000

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Pieter Rutter Cullis

Canadian

Active
Notified 31 Jul 2024
Residence Canada
DOB May 1946
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 outstanding 1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
2 Jun 2026AccountsAnnual accounts made up to 31 Dec 2025
9 May 2026IncorporationMemorandum Articles
9 May 2026IncorporationMemorandum Articles
19 Apr 2026ResolutionResolutions
27 Jan 2026OfficersTermination of Molly Stevens as director on 15 Jan 2026
2 Jun 2026 Accounts

Annual accounts made up to 31 Dec 2025

9 May 2026 Incorporation

Memorandum Articles

9 May 2026 Incorporation

Memorandum Articles

19 Apr 2026 Resolution

Resolutions

27 Jan 2026 Officers

Termination of Molly Stevens as director on 15 Jan 2026

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2025

1 weeks ago on 2 Jun 2026

Memorandum Articles

1 months ago on 9 May 2026

Memorandum Articles

1 months ago on 9 May 2026

Resolutions

1 months ago on 19 Apr 2026

Termination of Molly Stevens as director on 15 Jan 2026

4 months ago on 27 Jan 2026